International Stem Cell CORP (ISCO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 3.5M 7M 10.5M Q3 '24: 8.5M Q4 '24: 9.1M Q1 '25: 9.1M Q2 '25: 9.2M Q3 '25: 9.4M Q4 '25: 9.1M Q1 '26: 9.3M Q2 '26: 9.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 2M 4M 6M Q3 '24: 4.9M Q4 '24: 5.3M Q1 '25: 5.2M Q2 '25: 5.3M Q3 '25: 5.4M Q4 '25: 5.1M Q1 '26: 5.3M Q2 '26: 5.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-600K -400K -200K 0 200K 400K 600K Q3 '24: -543K Q4 '24: -68K Q1 '25: -105K Q2 '25: -87K Q3 '25: 97K Q4 '25: -267K Q1 '26: -242K Q2 '26: -444K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-750K -500K -250K 0 250K 500K 750K Q3 '24: -678K Q4 '24: -209K Q1 '25: -251K Q2 '25: -241K Q3 '25: -59K Q4 '25: -418K Q1 '26: -382K Q2 '26: -582K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 1.5M 3M 4.5M Q3 '24: 3.6M Q4 '24: 3.8M Q1 '25: 3.9M Q2 '25: 3.9M Q3 '25: 4M Q4 '25: 4M Q1 '26: 4M Q2 '26: 4.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-150K 0 150K 300K 450K Q3 '24: 248K Q4 '24: 13K Q1 '25: 433K Q2 '25: 110K Q3 '25: -98K Q4 '25: 8K Q1 '26: -98K Q2 '26: 369K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-300K -150K 0 150K 300K 450K Q3 '24: 83K Q4 '24: -153K Q1 '25: 270K Q2 '25: 35K Q3 '25: -139K Q4 '25: -35K Q1 '26: -159K Q2 '26: 333K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 3M 6M 9M Q1 '24: 8M Q2 '24: 8M Q3 '24: 8M Q1 '25: 8M Q2 '25: 8M Q3 '25: 8.2M Q1 '26: 8M Q2 '26: 8M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.09 -0.06 -0.03 0.00 0.03 0.06 0.09 Q3 '24: -0.07 Q4 '24: -0.04 Q1 '25: -0.04 Q2 '25: -0.04 Q3 '25: -0.02 Q4 '25: -0.06 Q1 '26: -0.06 Q2 '26: -0.08 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.